Skip to Main Content

Paper Details

Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications.
J Exp Clin Cancer Res
17
2020
Author NameAffiliation
Aleksandra A PandyraHeinrich-Heine-University, Universitatsstrasse 1
Aleksandra A PandyraHeinrich-Heine-University
  • 1 - 2

Datasets

Release 1.2